Drug CROs: Good Medicine for Investors

According to The Motley Fool, CROs are a solid investment for investors because they have experienced substantial growth because of increased research and development outsourcing by the biopharmaceutical industry. They outline specific CROs to watch in the coming years. What do you think? In a tough economic environment--are CROs solid for investment?

Quintiles partners with India’s Apollo Hospitals Group in Opening a Phase I Clinical Trials Unit

According to this article in outsourcing-pharma.com the CRO Quintiles has collaborated with India’s Apollo Hospitals Group in order to increase its presence in the fast-growing Indian clinical research market. The new unit is being built will have a capacity of 50 beds, which will increase to 100 if demand is developed. Eddie Caffrey , Quintiles’ senior vice president, mentions:

“This new Phase I unit will draw on the existing experience of Quintiles staff in India, including our established cardiology group.”

Kendle expands in India

According to a ClinPage, Kendle has opened a second office in western India. The new office in Ahmedabad continues its expansion in this area that is growing rapidly with CROs. They've operated in an office out of New Delhi since 2004.

Free Webinar: The Benefits of Establishing a Governance Committee

February 26, 2:00pm-3:00pm EST

Space is limited.

Reserve your Webinar seat now

https://www1.gotomeeting.com/register/221347807

How does a Sponsor and a Service Provider work together collaboratively as a Partnership? One of the ways is to establish a Governance Committee. The Governance Committee will cultivate a better relationship between the CRO and Sponsor.

When should a governance committee be established?
How do you determine the membership of the Governance Committee?
What should be in the Charter?
What should the frequency be?
What is the value of the Governance Committee and how will this be measured?

Register Today!

Use code: G1P1400W1BLOG

Read the January Partnerships with CROs LinkedIn Roundup

Here’s your chance to view our monthly newsletter that we send out to our Partnerships with CROs LinkedIn group with the latest updates in outsourcing and clinical development. Remember, to join our Partnerships with CROs LinkedIn group and update your email addresses on LinkedIn in order to receive it on an ongoing basis. Enjoy!

http://www.iirusa.com/upload/wysiwyg/CROs_January_Newsletter.html

Project Management in the Life Sciences: Results from a 2008 Survey and Comparison with Previous Surveys over the Last Decade

If you didn't have a chance to catch the web seminar "Project Management in the Life Sciences: Results from a 2008 Survey and Comparison with Previous Surveys over the Last Decade" with Dr. Jann Neilson of Wyeth, please do! It was a very informative session.



Check it out here:

https://www1.gotomeeting.com/register/403770168



About the web seminar:

The Project Management Institute Pharmaceutical Specific Interest Group has sponsored 50-plus item surveys in 2001, 2002, 2005, and in the fourth quarter of 2008. There have been up to 711 respondents to each of the surveys. We have determined people’s profiles (e.g. what country they live in), the organization’s profile (e.g. large pharma, small pharma, biotech, CRO, consultant, etc.), and most of the questions were about project management in the person’s organization.



The seminar will describe the most interesting data from the 2008 survey and how it compares to previous surveys. For example, there will be a comparison of how project management occurs in large pharma, small pharma and biotech. Differences in how project management is performed in the US vs. EU vs. Canada will be shown. Comparisons between virtual and defined project management groups will be explored. Single vs. multiple function project management groups will be contrasted. These and other comparisons will be made in order to shown how project management in the life sciences is performed. As a bonus we will compare compensation and vacations in the US, EU and Canada.

Indigo BioSystems Successfully Tests First Globally Accessible CRO Data Integration System

Three dimensional data can now be globally accessible thanks to the CRO Data Integration System that was just successfully implemented today from Indiana, USA to China. This will allow CROs across the world to access pertinent information and make quick decisions regarding the research of pharmaceuticals, etc. Before the implementation of this system, files were too big to send to other research labs, causing much delay for an industry whose survival is now based on being the first to find and release valuable information. How will this effect the world of CROs? We'd like to hear your thoughts.

From MSNBC